| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
| 06/18/2009 | WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/18/2009 | US20090156834 Process for making 2,2-bis (3,4-dicarboxyphenyl) hexafluoropropane |
| 06/18/2009 | US20090156668 Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof |
| 06/18/2009 | CA2706679A1 Novel compounds 010 |
| 06/17/2009 | EP2070534A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 06/17/2009 | EP2069334A1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| 06/17/2009 | EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 06/17/2009 | EP2069303A2 Antiviral protease inhibitors |
| 06/17/2009 | CN101460490A Substituted ring fused azines and their use in cancer therapy |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009071701A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | US20090149666 Method for the production of bisepoxides and dithiols |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | CA2707989A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/10/2009 | EP2066649A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | CN101450943A Method for synthesizing drug pranlukast from tetrahydrofuran path |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/04/2009 | WO2009067960A2 A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates |
| 06/04/2009 | US20090143602 Esters of 5-hydroxymethylfurfural and methods for their preparation |
| 06/04/2009 | US20090143587 Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143408 Compositions and methods for inhibiting cytochrome p450 2d6 |
| 06/03/2009 | EP1165553B1 C10 ester substituted taxanes as antitumor agents |
| 06/03/2009 | CN101445503A Stabilization of conjugates comprising a thiourea linker |
| 06/02/2009 | CA2474205C E2 displacement assay for identifying inhibitors of hpv |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/28/2009 | WO2009067401A1 Cycloalkyloxy-and hetξrocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | WO2009026657A8 Flavonoid ppar agonists |
| 05/28/2009 | WO2006036956A3 Therapeutic regimen for treating cancer using quassinoids and other chemotherapeutic agents |
| 05/28/2009 | US20090137796 Methods for the preparation of taxanes using chiral auxiliaries |
| 05/28/2009 | US20090137389 Having spiro 2-benzofuran-9-xanthene ring structures; exhibit first color (colorless) in crystalline form and second color (rhodamine chromophore) in liquid, amorphous form; thermal transfer systems; time independent temperature of coloration |
| 05/28/2009 | CA2706328A1 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| 05/27/2009 | CN101443328A Cocrystal of C-glycoside derivative and L-proline |
| 05/27/2009 | CN100491363C C7 ester-substituted taxane |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491316C Novel compounds, their preparation and use |
| 05/26/2009 | US7538233 Nitric oxide synthetase inhibitor; central nervous system disorders; multiple sclerosis; brain disorders; Parkinson's, Alzheimer's, Huntington's disease; amyotropic lateral sclerosis; antidepressants; schizophrenia |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
| 05/26/2009 | CA2337225C Novel antibacterial compounds |
| 05/22/2009 | WO2008135671A3 Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 05/21/2009 | US20090131663 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES |
| 05/20/2009 | EP2059514A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
| 05/20/2009 | CN101434601A 2-furyl-1H-benzimidazole-4-acidamide type derivative |
| 05/19/2009 | US7534903 Potassium channel blocker; cardiac arrhythmias; marked atrial-selective action profile; proliferative diseases, chronic inflammatory diseases, autoimmune diseases, multiple sclerosis |
| 05/19/2009 | US7534475 For preparation of thin phase retarder, such as wide-ranged polarization plate, which gives inverse wavelength distribution |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/14/2009 | WO2009061761A2 Fungicidal heterocyclic amines |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | US20090124683 Mercaptan and seleno-mercaptan compounds and methods of using them |
| 05/13/2009 | EP2057153A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 05/13/2009 | EP2057138A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | CN100486973C Novel benzodioxoles |
| 05/12/2009 | US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2007015262A3 A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2054395A2 Piperazine compounds with a herbicidal action |
| 05/06/2009 | CN101426787A Processes for the synthesis of 3-isobutylglutaric acid |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528157 EP4 receptor antagonists |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7527652 Dithiol compositions and methods of treating animal hides using the same |
| 04/30/2009 | WO2009055519A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009055516A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
| 04/30/2009 | WO2009052895A1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| 04/30/2009 | WO2008110813A3 Controlled release system |
| 04/30/2009 | US20090111987 reacting a 11H-indeno[1,2-c]quinolin-11-one derivative with hydroxylamine, then alkylation with an alkyl halide to yield )-11H-indeno[1,2-c]quinolin-11-one oxime derivatives, such as 6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one oxime, used in the treatment of cancers and tumors |
| 04/30/2009 | CA2704040A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/29/2009 | EP2053393A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound |
| 04/29/2009 | EP2053050A1 Dihydrochalcone similar to aspalathin and method for its manufacture |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | CN101421254A Diamino-1,3,5-triazines N-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
| 04/28/2009 | US7524974 6-Hydroxy--2-xanthenone derivatives 9-substituted by a phenyl ring with 1 or 2 substituents for trapping protons, metal ions (Na, Mg, Ca, Zn) or active oxygen species, and which may combine to form a fused ring such as anthracene or benzo-15-crown-5; after trapping compound formed is highly fluorescent |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524854 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 04/23/2009 | WO2009050352A2 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | CA2694377A1 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049510A1 Process for the preparation of candesartan cilexetil form i |